MicroRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Yu, Beiqin; Chen, Xuehua; Li, Jianfang; Gu, Qinlong; Zhu, Zhenggang; Li, Chen; Su, Liping; Liu, Bingya
• Is Part Of: BMC cancer. Volume 17:Issue 1(2017)
• Page Start: 1
• Page End: 11
• Publication Date: 2017-12
• Subjects: miR-29c -- NASP -- Gastric cancer -- Proliferation; Cancer -- Periodicals; 616.994005
• DOI: 10.1186/s12885-017-3096-9
• Languages: English
• ISSNs: 1471-2407

Abstract

Abstract Background Gastric cancer is one of the most common malignancies worldwide. Recent studies have shown that microRNAs play crucial roles in regulating cellular proliferation process in gastric cancer. MicroRNA-29c (miR-29c) acts as a tumor suppressor in different kinds of tumors. Methods Quantitative PCR was performed to evaluate miR-29c expression level in 67 patient gastric cancer tissues and 9 gastric cancer cell lines. The effects of miR-29c were explored by proliferation assay, soft agar colony formation assay, apoptosis and cell cycle analysis using flow cytometry. The target gene was predicted by bioinformatic algorithms and validated by dual luciferase reporter assay and Western blot analysis. Results In this study, we demonstrate that miR-29c is down-regulated in gastric cancer tissues and cell lines. We indicate that overexpression of miR-29c inhibits cell proliferation, promotes apoptosis and arrests cell cycle at G1/G0 phase. We additionally show that miR-29c exerts these effects by targeting Nuclear autoantigenic sperm protein (NASP). Moreover, depletion of NASP can elite the phenotypes caused by miR-29c. Conclusions These data suggest that miR-29c inhibits proliferation in gastric cancer and could potentially serve as an early biomarker and a novel therapy target.